Search Results - "Chielens, Deborah"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation by Bezerra, Evandro D., Flowers, Mary E., Onstad, Lynn E., Chielens, Deborah, Radich, Jerald, Higano, Celestia S.

    Published in Leukemia & lymphoma (19-09-2019)
    “…CML therapy has improved dramatically with the development of tyrosine kinase inhibitors (TKIs). Prior to the TKI era, we conducted two trials of…”
    Get full text
    Journal Article
  2. 2

    Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3⁺ T Cells by Lord, James D, Hackman, Robert C, Moklebust, Amanda, Thompson, John A, Higano, Celestia S, Chielens, Deborah, Steinbach, Gideon, McDonald, George B

    Published in Digestive diseases and sciences (01-05-2010)
    “…Ipilimumab is a humanized antibody to CTLA4 and is used to treat cancers refractory to conventional treatment. We treated 21 patients with refractory melanoma…”
    Get full text
    Journal Article
  3. 3

    Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3.sup.+ T Cells by Lord, James D, Hackman, Robert C, Moklebust, Amanda, Thompson, John A, Higano, Celestia S, Chielens, Deborah, Steinbach, Gideon

    Published in Digestive diseases and sciences (01-05-2010)
    “…Ipilimumab is a humanized antibody to CTLA4 and is used to treat cancers refractory to conventional treatment. We treated 21 patients with refractory melanoma…”
    Get full text
    Journal Article
  4. 4

    Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3 super(+) T Cells by Lord, James D, Hackman, Robert C, Moklebust, Amanda, Thompson, John A, Higano, Celestia S, Chielens, Deborah, Steinbach, Gideon, McDonald, George B

    Published in Digestive diseases and sciences (01-05-2010)
    “…Ipilimumab is a humanized antibody to CTLA4 and is used to treat cancers refractory to conventional treatment. We treated 21 patients with refractory melanoma…”
    Get full text
    Journal Article
  5. 5

    Use of α-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation by HIGANO, C. S, CHIELENS, D, RASKIND, W, BRYANT, E, FLOWERS, M. E. D, RADICH, J, CLIFT, R, APPELBAUM, F

    Published in Blood (01-10-1997)
    “…Fourteen patients with cytogenetic relapse of chronic myeloid leukemia (CML) after transplantation with unmanipulated bone marrow were treated with…”
    Get full text
    Journal Article
  6. 6

    Use of α-2a-Interferon to Treat Cytogenetic Relapse of Chronic Myeloid Leukemia After Marrow Transplantation by Higano, Celestia S., Chielens, Deborah, Raskind, Wendy, Bryant, Eileen, Flowers, Mary E.D., Radich, Jerald, Clift, Reginald, Appelbaum, Frederick

    Published in Blood (01-10-1997)
    “…Fourteen patients with cytogenetic relapse of chronic myeloid leukemia (CML) after transplantation with unmanipulated bone marrow were treated with…”
    Get full text
    Journal Article